Difference between revisions of "Fibroblastic/myofibroblastic tumours"

Jump to navigation Jump to search
Line 154: Line 154:
Notes:
Notes:
*[[Hypertrophic scar]]-like lesion; see also ''[[dermal scar]]''.
*[[Hypertrophic scar]]-like lesion; see also ''[[dermal scar]]''.
DDx:
*[[Gastrointestinal stromal tumour]].<ref name=pmid23020601>{{Cite journal  | last1 = Huss | first1 = S. | last2 = Nehles | first2 = J. | last3 = Binot | first3 = E. | last4 = Wardelmann | first4 = E. | last5 = Mittler | first5 = J. | last6 = Kleine | first6 = MA. | last7 = Künstlinger | first7 = H. | last8 = Hartmann | first8 = W. | last9 = Hohenberger | first9 = P. | title = β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. | journal = Histopathology | volume = 62 | issue = 2 | pages = 294-304 | month = Jan | year = 2013 | doi = 10.1111/j.1365-2559.2012.04355.x | PMID = 23020601 }}</ref>
*[[Retroperitoneal fibrosis]] - no beta-catenin staining.<ref name=pmid23020601/>


====Images====
====Images====
Line 167: Line 171:
===IHC===
===IHC===
Features:<ref name=Ref_WMSP609>{{Ref WMSP|609}}</ref>
Features:<ref name=Ref_WMSP609>{{Ref WMSP|609}}</ref>
*Beta-catenin +ve - '''important'''.
*Beta-catenin +ve (nuclear<ref name=pmid23020601/>) - '''important'''.
*SMA +ve ~50% of lesions.
*SMA +ve ~50% of lesions.


Retrieved from "https://librepathology.org/wiki/Fibroblastic/myofibroblastic_tumours"